Skip to main content
Access Bio, Inc. logo

Access Bio, Inc. — Investor Relations & Filings

Ticker · 950130 ISIN · KR8840090003 LEI · 335800Q5TV77F4L9Q648 KO Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2022-03-30 Declaration of Voting R…
Country IN India
Listing KO 950130

About Access Bio, Inc.

https://accessbio.net/

Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director/auditor appointments, and remuneration limits. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2022-03-30 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a specific corporate action related to share buybacks. According to the provided filing definitions, 'Transaction in Own Shares' (POS) is the correct category for reports concerning a company buying back its own shares.
2022-03-24 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) for COVID-19 diagnostic kit raw materials. It details the contract value, counterparty, and duration. Since this is a specific regulatory announcement of a material business event (a contract win) that does not fit into the other specific categories like M&A or financial reports, it is classified as a general regulatory filing.
2022-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Access Bio. It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a regulatory filing specifically announcing the submission of the audit report to the exchange, which is a standard requirement for public companies in Korea. Given the structure and content, it falls under the Audit Report / Information category. FY 2021
2022-03-22 Korean
사업보고서 (2021.12)
Annual Report Classification · 1% confidence The document is a '사업보고서' (Business Report) for the 20th fiscal year (2021), covering the period from January 1, 2021, to December 31, 2021. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which is the standard format for an Annual Report (10-K equivalent) in the South Korean regulatory context. FY 2021
2022-03-22 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, purpose, and agenda for the meeting. Since it is an announcement of an upcoming event rather than the presentation slides themselves, and it is a short regulatory notice, it falls under the category of a general regulatory announcement or report publication/event announcement. Given the specific nature of IR event scheduling in Korean regulatory filings, RNS is the most appropriate fallback category.
2022-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.